Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy

Abstract Background and Aim Vonoprazan as a new acid blocker has more potency and longer lasting acid suppression than proton pump inhibitors. Whether the efficacy of vonoprazan‐based triple therapy is comparable with or even better than that of currently recommended first‐line therapies is still un...

Full description

Bibliographic Details
Main Authors: Yu‐Tse Chiu, Fu‐Jen Lee, Chen‐Ya Kuo, Yang‐Chao Lin, Kai‐Shun Liang, Liang‐Wei Tseng, Yu‐Tsung Chen, Chi‐Yang Chang
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:JGH Open
Subjects:
antibacterial agents
Helicobacter pylori
potassium‐competitive acid blocker
proton pump inhibitors
Online Access:https://doi.org/10.1002/jgh3.12858

Similar Items

Similar Items